Alimta is currently available for the treatment of malignant pleural mesothelioma as well as secondary treatment for certain types of lung cancer.

It is approved in the United States, European Union, Australia, Canada, and a number of other countries.

Consult your healthcare provider about where to actually get Alimta. Because it is administered intraveneously, it is usually sold through the doctor, clinic, or hospital